about
Gender differences in right ventricular function in patients with non-ischaemic cardiomyopathy.Data from acellular human heart matrixLethal heparin-induced thrombocytopenia after transfemoral aortic valve implantation.Degree of dyspnoea at admission and discharge in patients with heart failure and respiratory diseases.Noninvasive localization of maximal frequency sites of atrial fibrillation by body surface potential mappingBody surface localization of left and right atrial high-frequency rotors in atrial fibrillation patients: a clinical-computational study.The role of elastic restoring forces in right-ventricular fillingMALDI-Imaging Mass Spectrometry: a step forward in the anatomopathological characterization of stenotic aortic valve tissue.Cardiovascular safety of anagrelide in healthy subjects: effects of caffeine and food intake on pharmacokinetics and adverse reactionsHigh-rate pacing-induced atrial fibrillation effectively reveals properties of spontaneously occurring paroxysmal atrial fibrillation in humans.End-of-life care in a cardiology department: have we improved?Topology of blood transport in the human left ventricle by novel processing of Doppler echocardiography.New-onset atrial fibrillation and prognosis in nonagenarians after acute myocardial infarctionCell Expansion-Dependent Inflammatory and Metabolic Profile of Human Bone Marrow Mesenchymal Stem Cells.Intraventricular vortex properties in nonischemic dilated cardiomyopathy.Do the spatial characteristics of myocardial scar tissue determine the risk of ventricular arrhythmias?The vascular stem cell niche.Direct injury to right coronary artery in patients undergoing tricuspid annuloplasty.Rationale and Design of a Clinical Trial to Evaluate the Safety and Efficacy of Intracoronary Infusion of Allogeneic Human Cardiac Stem Cells in Patients With Acute Myocardial Infarction and Left Ventricular Dysfunction: The Randomized Multicenter DEfficacy and safety of rivaroxaban in real-life patients with atrial fibrillation.Current Indications for Implantable Cardioverter Defibrillators in Non-Ischemic Cardiomyopathies and Channelopathies.Comparison of the safety and feasibility of arrhythmia ablation using the Amigo Robotic Remote Catheter System versus manual ablation.Autologous and allogeneic cardiac stem cell therapy for cardiovascular diseases.Presence and stability of rotors in atrial fibrillation: evidence and therapeutic implications.Two-Year Follow Up After Surgical Versus Percutaneous Paravalvular Leak Closure: A Non-Randomized Analysis.Hospital without dyspnea: rationale and design of a multidisciplinary intervention.Role of atrial tissue remodeling on rotor dynamics: an in vitro study.Risk factors for excess mortality in adults with congenital heart diseases.Systemic vascular load in calcific degenerative aortic valve stenosis: insight from percutaneous valve replacement.Radial versus femoral access for percutaneous coronary intervention in ST-elevation myocardial infarction patients treated with fibrinolysis: Results from the randomized routine early invasive clinical trials.Immediate post-procedure bridging with unfractioned heparin versus low molecular weight heparin in patients undergoing radiofrequency ablation for atrial fibrillation with an interrupted oral anticoagulation strategy.Prognostic Impact of Age and Hemoglobin in Acute ST-Segment Elevation Myocardial Infarction Treated With Reperfusion Therapy.A clinical method for mapping and quantifying blood stasis in the left ventricle.[Profile of heart failure according to the department of admission. Implications for multidisciplinary management].Sex differences in acute myocardial infarction: Is it only the age?Outpatient follow-up during the first year after heart transplantation, is it feasible?Puncture Versus Surgical Cutdown Complications of Transfemoral Aortic Valve Implantation (from the Spanish TAVI Registry).Consistency of benefit from an early invasive strategy after fibrinolysis: a patient-level meta-analysis.Early Intravenous Beta-Blockers in Patients With ST-Segment Elevation Myocardial Infarction Before Primary Percutaneous Coronary Intervention.Balance between sodium and calcium currents underlying chronic atrial fibrillation termination: An in silico intersubject variability study.
P50
Q30397963-40F76C7E-33FC-46D5-BF07-B4750DFE2BF9Q31109778-BAEF7846-2AF0-40ED-A43D-6EDCE2F3C81BQ33434689-9259F9B3-2E75-43D2-967D-4E631CC022B9Q33717352-A1D2ACDB-AEFC-4408-B19C-9D6F462534A3Q34938686-5DEA2E99-FA31-42FC-8CAC-BA69FEDA13E9Q34938719-A028B0D8-71EE-4515-B4D1-39406AB5DF43Q36027821-1CAE282E-2197-490B-8D42-24469D1323CBQ36039005-C1D62A69-22BD-439A-861F-4199DD61ED4BQ36650181-2F0BD6BF-E341-477D-92A4-C8F4B56E07D5Q36971587-14E62C89-F844-4E0F-8823-EC18E7239FEBQ37201516-1B5F6DDC-9945-4D6A-B818-951A0B0D0219Q37297214-7DF836E8-9FC4-4721-B743-A6E96370CB9EQ37299829-77C7D158-DF3E-40C8-A5AE-61578716990CQ37416143-657CE007-75DD-48A9-BA69-9B0446D56319Q37629257-41E5B664-DD25-4341-97F5-1F406E88AF23Q38003595-CE07396E-5404-4739-B2D4-0FDC4A5967E3Q38014348-BAD5F8AB-31F9-4462-83AD-B8A85D9FEBF6Q38188172-30189C95-0D9E-4804-BF13-6F8A4C9DCA44Q38376515-9112A7AF-4E8E-4A76-927D-5904F49BEA35Q38386998-0FF787D9-80F1-423A-9315-36F4B6D8FCADQ38407565-5E5811A9-991B-497F-9047-3C3FF3D7874FQ38437575-95496DFE-DDDD-4ADB-8E00-4E817C8A1336Q38677714-29D45FC0-3A2B-4965-A5C6-02D246BE9CA7Q38703108-279E5B56-51DE-4AF7-B0F9-941A12DCA5ADQ38762296-57C0F0AB-7608-4CA4-9067-1A6A1386C2FEQ38823417-4AB8DF2D-21D9-4EFE-896B-EC0172BE5D93Q38832340-AEF934ED-53C4-4CCF-9EF4-DAA0433ABD7BQ39026257-F8A92038-36C4-4A4A-B50E-D18B86CF8F5EQ39194585-949B373E-F3FA-41AC-BA30-CB98963CF9F3Q39820085-50AF35CA-687B-4E95-AC05-75C3AA66BB80Q40135161-8D9804FB-4A3D-4F1C-89CD-C2907ACBFF0AQ40224675-18A6F156-9CE7-48A3-A427-912EAF0DFE31Q40338532-6B5D6FCA-6540-436F-8185-35C61F63A4AFQ40397428-E75B5950-842C-416F-8C99-F5809B04E5B8Q40444101-75581898-E7B8-4AFD-8FD6-5F9ED842678DQ40445199-E5EA9C8E-93B8-400C-8B91-9B293962E0A4Q40667388-A42311F1-3B75-450D-A9C1-F236E97D8F93Q40735873-E933BBF7-750B-450C-AA12-61486587E724Q40815387-13C5AEFA-FBC5-48C9-BB1C-45CE686E56E2Q41029009-06A1587B-C828-45C8-BEBC-9D535ADC2A28
P50
description
researcher ORCID ID = 0000-0001-5501-5275
@en
name
Francisco Fernández-Avilés
@ast
Francisco Fernández-Avilés
@en
Francisco Fernández-Avilés
@es
Francisco Fernández-Avilés
@nl
type
label
Francisco Fernández-Avilés
@ast
Francisco Fernández-Avilés
@en
Francisco Fernández-Avilés
@es
Francisco Fernández-Avilés
@nl
prefLabel
Francisco Fernández-Avilés
@ast
Francisco Fernández-Avilés
@en
Francisco Fernández-Avilés
@es
Francisco Fernández-Avilés
@nl
P21
P31
P496
0000-0001-5501-5275